Embla Medical hf's gross profit for the
three
months ended in Mar. 2026 was $143.1 Mil. Embla Medical hf's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was $593.8 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Embla Medical hf's gross profit for the
three
months ended in Mar. 2026 was $143.1 Mil. Embla Medical hf's Revenue for the
three
months ended in Mar. 2026 was $232.4 Mil. Therefore, Embla Medical hf's Gross Margin % for the quarter that ended in Mar. 2026 was 61.56%.
Embla Medical hf had a gross margin of 61.56% for the quarter that ended in Mar. 2026 => Durable competitive advantage
During the past 13 years, the highestGross Margin % of Embla Medical hf was 63.92%. The lowest was 61.19%. And the median was 62.47%.
Embla Medical hf (OTCPK:OSSFF) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Embla Medical hf had a gross margin of 61.56% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Embla Medical hf Gross Profit Related Terms
Embla Medical hf Gross Profit Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Embla Medical hf's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Gross Profit distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $593.8 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Embla Medical hf (OSSFF) has a Gross Profit of $593.8 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Embla Medical hf and its competitors.
Is Embla Medical hf's Gross Profit too high?
Embla Medical hf's current Gross Profit is $593.8 Mil. Overall, Embla Medical hf has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Gross Profit compare to ABT and SYK?
Embla Medical hf's Gross Profit of $593.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Gross Profit is $593.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Gross Profit of $593.8 Mil. The stock's GF Value™ is $5.48, compared to a current price of $4.15 — trading 24.3% below its estimated fair value. The current Gross Profit is $593.8 Mil. Embla Medical hf's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Gross Profit is $593.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 24.3% below its estimated GF Value™ of $5.48.
Key valuation signals for OSSFF:
Gross Profit: $593.8 Mil
GF Value™: $5.48 vs. price of $4.15 (24.3% below fair value)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
93GF Score
Get the complete analysis for OSSFF
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
